These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34561865)

  • 1. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.
    Jones CM; Houry D; Han B; Baldwin G; Vivolo-Kantor A; Compton WM
    Ann N Y Acad Sci; 2022 Feb; 1508(1):3-22. PubMed ID: 34561865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids.
    Cano M; Huang Y
    Drug Alcohol Depend; 2021 Jan; 218():108384. PubMed ID: 33158665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
    Ciccarone D
    Curr Opin Psychiatry; 2021 Jul; 34(4):344-350. PubMed ID: 33965972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms.
    Jones CM; Bekheet F; Park JN; Alexander GC
    Epidemiol Rev; 2020 Jan; 42(1):154-166. PubMed ID: 33511987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
    Han Y; Yan W; Zheng Y; Khan MZ; Yuan K; Lu L
    Transl Psychiatry; 2019 Nov; 9(1):282. PubMed ID: 31712552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.
    O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
    Yeo Y; Johnson R; Heng C
    Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What would it really take to solve the overdose epidemic in the United States?
    Rivera BD; Friedman SR
    Int J Drug Policy; 2024 Jun; 128():104435. PubMed ID: 38729061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
    Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
    Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
    Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
    Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.
    Gladden RM; O'Donnell J; Mattson CL; Seth P
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(34):737-744. PubMed ID: 31465320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017.
    Kariisa M; Scholl L; Wilson N; Seth P; Hoots B
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):388-395. PubMed ID: 31048676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between law enforcement seizures of illicit drugs and drug overdose deaths involving cocaine and methamphetamine, Ohio, 2014-2019.
    Zibbell JE; Clarke SD; Kral AH; Richardson NJ; Cauchon D; Aldridge A
    Drug Alcohol Depend; 2022 Mar; 232():109341. PubMed ID: 35134733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry.
    Fredericksen RJ; Baker R; Sibley A; Estadt AT; Colston D; Mixson LS; Walters S; Bresett J; Levander XA; Leichtling G; Davy-Mendez T; Powell M; Stopka TJ; Pho M; Feinberg J; Ezell J; Zule W; Seal D; Cooper HLF; Whitney BM; Delaney JAC; Crane HM; Tsui JI
    Harm Reduct J; 2024 Apr; 21(1):74. PubMed ID: 38561753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine.
    Sun R; Sauda TH; Hoopsick RA
    Harm Reduct J; 2024 Jun; 21(1):119. PubMed ID: 38890736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xylazine and Overdoses: Trends, Concerns, and Recommendations.
    Alexander RS; Canver BR; Sue KL; Morford KL
    Am J Public Health; 2022 Aug; 112(8):1212-1216. PubMed ID: 35830662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.